Effect of Liraglutide on Automated Closed-loop Glucose Control in Type 1 Diabetes

Summary

"Closed loop artificial pancreas" systems have been under development for the control of blood sugars in those living with diabetes. These systems consist of a continuous glucose sensor, which sends a signal to a computer program that automatically determines how much insulin to give. The computer program then tells an insulin pump to deliver the insulin. While such systems have been tested under a number of conditions, post-meal blood sugars are difficult to control. This study is designed to see if liraglutide, a glucagon like peptide receptor agonist, can help minimize the post meal blood sugar spikes in subjects with type 1 diabetes while they are on a closed loop system.

Timeline

Start

2013-02

Primary completion

2015-11

Completion

2015-11

Outcome

Missed primary endpoint

registry analysis (unspecified test); Closed Loop Insulin Delivery vs Closed Loop + Liraglutide; p = 0.05; Wilcoxon Matched Pairs signed rank tests NCT01856790 ↗

Drugs

Indications